Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies
Executive Summary
In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to Washington Analysis vice president and senior healthcare analyst John Leppard about the Center for Medicare and Medicaid’s Transitional Coverage Of Emerging Technologies pathway, or TCET. He breaks down the pathway and discusses its pros and cons, as well as potential next steps for the agency. We also explore the history of breakthrough device coverage as well as the challenges for coverage of digital health devices.
Further Reading:
CMS Promises Actions To Support TCET Pathway
Market Fast Track Or Regulatory Trap? Consultant Ken Block On US FDA’s Breakthrough Devices Program
Expanding Device Eligibility And Other Suggestions For CMS’s TCET Pathway
Industry Proposes TCET Timeline, CED Changes During CMS Stakeholder Call
CMS Proposes New TCET Pathway, But How Much Difference Will It Make?
Further Listening:
Our other podcasts are available on the Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn - also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider.